HEPATOLITE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hepatolite, and when can generic versions of Hepatolite launch?
Hepatolite is a drug marketed by Sun Pharm Inds Inc and is included in one NDA.
The generic ingredient in HEPATOLITE is technetium tc-99m disofenin kit. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m disofenin kit profile page.
Summary for HEPATOLITE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | HEPATOLITE at DailyMed |
US Patents and Regulatory Information for HEPATOLITE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Inds Inc | HEPATOLITE | technetium tc-99m disofenin kit | INJECTABLE;INJECTION | 018467-001 | Mar 16, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |